Marshall Wace, LLP West Pharmaceutical Services Inc Transaction History

Marshall Wace, LLP

$72.2 Billion
Q2 2024

A detailed history of Marshall Wace, LLP transactions in West Pharmaceutical Services Inc stock. As of the latest transaction made, Marshall Wace, LLP holds 47,979 shares of WST stock, worth $14.9 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

47,979

Previous 375,678 87.23%

Holding current value

$14.9 Million

Previous $149 Million 89.37%

% of portfolio

0.02%

Previous 0.23%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$314.68 - $395.94 $103 Million - $130 Million	-327,699 Reduced 87.23%	47,979 $15.8 Million
Q1 2024 May 15, 2024	BUY	$338.27 - $413.0 $106 Million - $129 Million	312,531 Added 494.93%	375,678 $149 Million
Q4 2023 Feb 14, 2024	SELL	$318.29 - $392.21 $28.8 Million - $35.5 Million	-90,614 Reduced 58.93%	63,147 $22.2 Million
Q3 2023 Nov 14, 2023	BUY	$354.9 - $412.41 $40.8 Million - $47.4 Million	114,994 Added 296.63%	153,761 $57.7 Million
Q2 2023 Aug 14, 2023	SELL	$334.63 - $382.47 $6.45 Million - $7.37 Million	-19,272 Reduced 33.21%	38,767 $14.8 Million
Q1 2023 May 15, 2023	BUY	$232.5 - $346.47 $13.2 Million - $19.7 Million	56,983 Added 5396.12%	58,039 $20.1 Million
Q4 2022 Feb 14, 2023	SELL	$209.34 - $261.61 $23.5 Million - $29.3 Million	-112,121 Reduced 99.07%	1,056 $248,000
Q3 2022 Nov 14, 2022	BUY	$246.08 - $343.65 $21.6 Million - $30.1 Million	87,634 Added 343.08%	113,177 $27.8 Million
Q2 2022 Aug 15, 2022	BUY	$280.61 - $420.45 $7.17 Million - $10.7 Million	25,543 New	25,543 $7.72 Million
Q1 2022 May 16, 2022	SELL	$357.49 - $445.92 $71,140 - $88,738	-199 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$402.25 - $471.34 $100 Million - $117 Million	-248,900 Reduced 99.92%	199 $93,000
Q3 2021 Nov 15, 2021	BUY	$363.01 - $468.47 $34 Million - $43.9 Million	93,783 Added 60.38%	249,099 $106 Million
Q2 2021 Aug 13, 2021	BUY	$284.77 - $363.2 $44.2 Million - $56.4 Million	155,316 New	155,316 $55.8 Million
Q4 2020 Feb 16, 2021	SELL	$261.16 - $301.66 $2.73 Million - $3.15 Million	-10,445 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$224.99 - $288.02 $397,557 - $508,931	-1,767 Reduced 14.47%	10,445 $2.87 Million
Q2 2020 Aug 13, 2020	BUY	$149.8 - $227.17 $1.83 Million - $2.77 Million	12,212 New	12,212 $2.77 Million
Q1 2020 May 15, 2020	SELL	$128.96 - $174.76 $1.4 Million - $1.89 Million	-10,825 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$137.6 - $151.21 $2.47 Million - $2.71 Million	-17,926 Reduced 62.35%	10,825 $1.63 Million
Q3 2019 Nov 14, 2019	BUY	$121.41 - $150.02 $3.49 Million - $4.31 Million	28,751 New	28,751 $4.08 Million
Q2 2019 Aug 14, 2019	SELL	$111.27 - $125.15 $8.92 Million - $10 Million	-80,140 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$94.53 - $110.2 $7.58 Million - $8.83 Million	80,140 New	80,140 $8.83 Million
Q4 2018 Feb 14, 2019	SELL	$93.0 - $123.98 $9.24 Million - $12.3 Million	-99,369 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$98.01 - $123.47 $8.38 Million - $10.6 Million	85,464 Added 614.63%	99,369 $12.3 Million
Q2 2018 Aug 14, 2018	BUY	$83.32 - $101.88 $1.16 Million - $1.42 Million	13,905 New	13,905 $1.38 Million

Others Institutions Holding WST

# of Institutions

839

Shares Held

65.1M

Call Options Held

345K

Put Options Held

211K

View Full List

About WEST PHARMACEUTICAL SERVICES INC

Ticker WST
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 74,033,000
Market Cap $23B
Description
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers sto...

More about WST

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.

Account

Marshall Wace, LLP West Pharmaceutical Services Inc Transaction History